Cargando…
A promising antitumor method: Targeting CSC with immune cells modified with CAR
Tumors pose a great threat to human health; as a subgroup of tumor cells, cancer stem cells (CSCs) contribute to the genesis, development, metastasis, and recurrence of tumors because of their enhanced proliferation and multidirectional differentiation. Thus, a critical step in tumor treatment is to...
Autores principales: | Huang, Binjie, Miao, Lele, Liu, Jie, Zhang, Jiaxing, Li, Yumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403009/ https://www.ncbi.nlm.nih.gov/pubmed/36032145 http://dx.doi.org/10.3389/fimmu.2022.937327 |
Ejemplares similares
-
Reactions Related to CAR-T Cell Therapy
por: Miao, Lele, et al.
Publicado: (2021) -
Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021) -
Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future
por: Zhang, Zhengchao, et al.
Publicado: (2021) -
A Bibliometric and Knowledge-Map Analysis of CAR-T Cells From 2009 to 2021
por: Miao, Lele, et al.
Publicado: (2022) -
Special Chimeric Antigen Receptor (CAR) Modifications of T Cells: A Review
por: Miao, Lele, et al.
Publicado: (2022)